Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats

[1]  A. Kaya,et al.  Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier. , 2013, Medical hypotheses.

[2]  Kojiro Sato.  The IL-23/IL-17 axis as a therapeutic target. , 2013, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[3]  J. Myśliwska,et al.  Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. , 2013, Human immunology.

[4]  S. Ljubic,et al.  The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. , 2013, Collegium antropologicum.

[5]  Fu-Tong Liu,et al.  Galectin-3 Negatively Regulates Dendritic Cell Production of IL-23/IL-17–Axis Cytokines in Infection by Histoplasma capsulatum , 2013, The Journal of Immunology.

[6]  D. Cua,et al.  Th17 cell development: from the cradle to the grave , 2013, Immunological reviews.

[7]  J. Brandon,et al.  Anti-IL-23p19 therapy inhibits the adoptive transfer of syngeneic graft-versus-host disease. , 2013, Cytokine.

[8]  K. Kohyama,et al.  Therapeutic gene silencing with siRNA for IL-23 but not for IL-17 suppresses the development of experimental autoimmune encephalomyelitis in rats , 2013, Journal of Neuroimmunology.

[9]  Xuefeng Yu,et al.  Th17 cells in type 1 diabetes. , 2012, Cellular immunology.

[10]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[11]  S. Kaveri,et al.  Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. , 2012, The American journal of pathology.

[12]  Y. Bi,et al.  Direct and Indirect Regulatory Mechanisms in TH17 cell Differentiation and Functions , 2012, Scandinavian journal of immunology.

[13]  C. Cheung,et al.  Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy , 2012, Molecular vision.

[14]  E. Toussirot.  The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. , 2012, Inflammation & allergy drug targets.

[15]  Sung-Hwan Park,et al.  TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome , 2012, Arthritis Research & Therapy.

[16]  Hong Wang,et al.  [Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis]. , 2012, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[17]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[18]  J. Zagury,et al.  Active immunization against IL-23p19 improves experimental arthritis. , 2011, Vaccine.

[19]  Ross Milne,et al.  Advanced glycation end products and diabetic retinopathy , 2011, Amino Acids.

[20]  A. Kijlstra,et al.  The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells , 2011, PloS one.

[21]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[22]  J. Ilonen,et al.  IL-17 Immunity in Human Type 1 Diabetes , 2010, The Journal of Immunology.

[23]  H. Cheroutre,et al.  More stories on Th17 cells , 2009, Cell Research.

[24]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[25]  S. Nakae,et al.  The roles of IL‐17A in inflammatory immune responses and host defense against pathogens , 2008, Immunological reviews.

[26]  D. Zipris.  Innate immunity and its role in type 1 diabetes , 2008, Current opinion in endocrinology, diabetes, and obesity.

[27]  Chen Dong,et al.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.

[28]  H. S. Kim,et al.  The clinical role of IL‐23p19 in patients with rheumatoid arthritis , 2007, Scandinavian journal of rheumatology.

[29]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[30]  S. Jahan,et al.  Inverse relationship of serum IL-17 with type-II diabetes retinopathy. , 2013, Clinical laboratory.

[31]  M. Nawaz,et al.  Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. , 2012, Journal of diabetes and its complications.

[32]  D. Antonetti,et al.  The blood-retinal barrier: structure and functional significance. , 2011, Methods in molecular biology.